drugset / Trial / NCT00614250
Evaluation of the Effect of AVE0657 on Obstructive Sleep Apnea
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective of this study is to assess the activity of 4 escalating doses of AVE0657 in comparison to placebo in patients with Obstructive Sleep Apnea Hypopnea Syndrome.
Timeline
- Start
- 2008-01
- Primary completion
- 2009-01
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AVE0657 | Unknown | — | — |